- PathHunter eXpress Kits Combined with LabChip Microfluidic Instruments Provide a Comprehensive, High Quality, Easy-to-Use GPCR Assay Solution -
HOPKINTON, Mass. and FREMONT, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) and DiscoveRx, today announced the commercial availability of PathHunter(TM) eXpress Beta-Arrestin kits for use with Caliper's LabChip(R) 3000 and EZ Reader(TM) platforms to conduct cellular G protein-coupled receptor (GPCR) assays. This milestone is part of the collaboration between Caliper and DiscoveRx, announced in May 2008, to provide a powerful and comprehensive suite of solutions to assist pharmaceutical and biotechnology researchers in more efficiently discovering new drugs.
"This joint solution enables researchers to quickly assess potency and potential side effects of new drug candidates in a cellular environment, which accelerates overall drug discovery programs," said Nate Cosper, Director of Marketing at Caliper Life Sciences. "Achievement of this commercial milestone underscores Caliper's commitment to partnering with leading technology companies like DiscoveRx to develop innovative solutions that provide higher quality and more reproducible data, improve scientific workflows and enable novel research approaches."
Caliper's LabChip 3000 and EZ Reader platforms, a suite of instruments
for screening and profiling potential drug candidates, utilize microfluidic
separation and direct detection of both substrates and products to generate
high quality, reproducible data to qualify potential lead candidates.
Caliper provides researchers in neuroscience, cardiovascular, and
inflammation therapeutic areas with platforms and services for target
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved